Activated T lymphocytes support osteoclast formation in vitro

Nicole J. Horwood, Vicky Kartsogiannis, Julian M.W. Quinn, Evangelos Romas, T. John Martin, Matthew T. Gillespie

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Osteoblastic stromal cells are capable of supporting osteoclast formation from hematopoietic precursors in the presence of osteotropic factors such as 1α,25(OH)2D3, PTH, and IL-11. Osteoblastic stromal cells produce receptor activator of NF-κB ligand (RANKL), a type II membrane protein of the TNF ligand family, in response to these agents. Activated T lymphocytes also produce RANKL; however, the ability of this cell type to support osteoclast formation in vitro is unknown. Human PBMC-derived T cells, extracted using αCD3-coated magnetic beads, were cocultured with adherent murine spleen cells in the presence of Con A and a panel of cytokines. In the presence of Con A, bona fide osteoclasts were formed in vitro with activated T cells: IL-1α and TGFβ further enhanced osteoclast numbers. PBMC-derived lymphocytes showed an increase in the mRNA expression of RANKL within 24 h of treatment with the same agents that were used to induce osteoclast formation. In synovial tissue sections with lymphoid infiltrates from RA patients, the expression of RANKL was demonstrated in CD3+ T cells. The ability of activated T lymphocytes to support osteoclast formation may provide a mechanism for the potentiation of osteoclast formation and bone resorption in disease states such as rheumatoid arthritis.

Original languageEnglish
Pages (from-to)144-150
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume265
Issue number1
DOIs
Publication statusPublished - 11 Nov 1999
Externally publishedYes

Cite this

Horwood, Nicole J. ; Kartsogiannis, Vicky ; Quinn, Julian M.W. ; Romas, Evangelos ; Martin, T. John ; Gillespie, Matthew T. / Activated T lymphocytes support osteoclast formation in vitro. In: Biochemical and Biophysical Research Communications. 1999 ; Vol. 265, No. 1. pp. 144-150.
@article{59087a19c58a4f43a598166b3b2f948c,
title = "Activated T lymphocytes support osteoclast formation in vitro",
abstract = "Osteoblastic stromal cells are capable of supporting osteoclast formation from hematopoietic precursors in the presence of osteotropic factors such as 1α,25(OH)2D3, PTH, and IL-11. Osteoblastic stromal cells produce receptor activator of NF-κB ligand (RANKL), a type II membrane protein of the TNF ligand family, in response to these agents. Activated T lymphocytes also produce RANKL; however, the ability of this cell type to support osteoclast formation in vitro is unknown. Human PBMC-derived T cells, extracted using αCD3-coated magnetic beads, were cocultured with adherent murine spleen cells in the presence of Con A and a panel of cytokines. In the presence of Con A, bona fide osteoclasts were formed in vitro with activated T cells: IL-1α and TGFβ further enhanced osteoclast numbers. PBMC-derived lymphocytes showed an increase in the mRNA expression of RANKL within 24 h of treatment with the same agents that were used to induce osteoclast formation. In synovial tissue sections with lymphoid infiltrates from RA patients, the expression of RANKL was demonstrated in CD3+ T cells. The ability of activated T lymphocytes to support osteoclast formation may provide a mechanism for the potentiation of osteoclast formation and bone resorption in disease states such as rheumatoid arthritis.",
author = "Horwood, {Nicole J.} and Vicky Kartsogiannis and Quinn, {Julian M.W.} and Evangelos Romas and Martin, {T. John} and Gillespie, {Matthew T.}",
year = "1999",
month = "11",
day = "11",
doi = "10.1006/bbrc.1999.1623",
language = "English",
volume = "265",
pages = "144--150",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier",
number = "1",

}

Activated T lymphocytes support osteoclast formation in vitro. / Horwood, Nicole J.; Kartsogiannis, Vicky; Quinn, Julian M.W.; Romas, Evangelos; Martin, T. John; Gillespie, Matthew T.

In: Biochemical and Biophysical Research Communications, Vol. 265, No. 1, 11.11.1999, p. 144-150.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Activated T lymphocytes support osteoclast formation in vitro

AU - Horwood, Nicole J.

AU - Kartsogiannis, Vicky

AU - Quinn, Julian M.W.

AU - Romas, Evangelos

AU - Martin, T. John

AU - Gillespie, Matthew T.

PY - 1999/11/11

Y1 - 1999/11/11

N2 - Osteoblastic stromal cells are capable of supporting osteoclast formation from hematopoietic precursors in the presence of osteotropic factors such as 1α,25(OH)2D3, PTH, and IL-11. Osteoblastic stromal cells produce receptor activator of NF-κB ligand (RANKL), a type II membrane protein of the TNF ligand family, in response to these agents. Activated T lymphocytes also produce RANKL; however, the ability of this cell type to support osteoclast formation in vitro is unknown. Human PBMC-derived T cells, extracted using αCD3-coated magnetic beads, were cocultured with adherent murine spleen cells in the presence of Con A and a panel of cytokines. In the presence of Con A, bona fide osteoclasts were formed in vitro with activated T cells: IL-1α and TGFβ further enhanced osteoclast numbers. PBMC-derived lymphocytes showed an increase in the mRNA expression of RANKL within 24 h of treatment with the same agents that were used to induce osteoclast formation. In synovial tissue sections with lymphoid infiltrates from RA patients, the expression of RANKL was demonstrated in CD3+ T cells. The ability of activated T lymphocytes to support osteoclast formation may provide a mechanism for the potentiation of osteoclast formation and bone resorption in disease states such as rheumatoid arthritis.

AB - Osteoblastic stromal cells are capable of supporting osteoclast formation from hematopoietic precursors in the presence of osteotropic factors such as 1α,25(OH)2D3, PTH, and IL-11. Osteoblastic stromal cells produce receptor activator of NF-κB ligand (RANKL), a type II membrane protein of the TNF ligand family, in response to these agents. Activated T lymphocytes also produce RANKL; however, the ability of this cell type to support osteoclast formation in vitro is unknown. Human PBMC-derived T cells, extracted using αCD3-coated magnetic beads, were cocultured with adherent murine spleen cells in the presence of Con A and a panel of cytokines. In the presence of Con A, bona fide osteoclasts were formed in vitro with activated T cells: IL-1α and TGFβ further enhanced osteoclast numbers. PBMC-derived lymphocytes showed an increase in the mRNA expression of RANKL within 24 h of treatment with the same agents that were used to induce osteoclast formation. In synovial tissue sections with lymphoid infiltrates from RA patients, the expression of RANKL was demonstrated in CD3+ T cells. The ability of activated T lymphocytes to support osteoclast formation may provide a mechanism for the potentiation of osteoclast formation and bone resorption in disease states such as rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=0033547343&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1999.1623

DO - 10.1006/bbrc.1999.1623

M3 - Article

VL - 265

SP - 144

EP - 150

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -